Does long term aspirin prevent cancer?

Potentially, but trials specifically designed to answer this question are needed

[1]  P. Rothwell,et al.  Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials , 2011, The Lancet.

[2]  Brendan Delaney,et al.  Diagnosis and management of Barrett’s oesophagus , 2010, BMJ : British Medical Journal.

[3]  G. Guyatt,et al.  Errors in the Conduct of Systematic Reviews of Pharmacological Interventions for Irritable Bowel Syndrome , 2010, The American Journal of Gastroenterology.

[4]  M. Thun,et al.  Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement. , 2009, The Lancet. Oncology.

[5]  P. Moayyedi,et al.  Proton pump inhibitors and clopidogrel - hazardous drug interaction or hazardous interpretation of data? , 2009, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[6]  P. Moayyedi,et al.  International Comparisons of Manpower in Gastroenterology , 2007, The American Journal of Gastroenterology.

[7]  P. Moayyedi,et al.  Re: Cost-effectiveness of aspirin chemoprevention for Barrett's esophagus. , 2004, Journal of the National Cancer Institute.

[8]  N. Nishioka,et al.  Cost-effectiveness of aspirin chemoprevention for Barrett's esophagus. , 2003, Journal of the National Cancer Institute.

[9]  N. Edvardsson,et al.  Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris , 1992, The Lancet.

[10]  J. Jankowski,et al.  Chemoprevention in Barrett's esophagus: A pill a day? , 2011, Gastrointestinal endoscopy clinics of North America.

[11]  S. Juul-Möller,et al.  Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris. The Swedish Angina Pectoris Aspirin Trial (SAPAT) Group. , 1992, Lancet.